Results of bridging therapy with standard-dose versus non-standard-dose intravenous thrombolysis and mechanical thrombectomy in acute ischemic stroke patients
Keywords
Abstract
Objectives: To compare effectiveness and safety of mechanical thrombectomy applied in patients with acute ischemic stroke due to large vessel occlusions. Subjects and methods: A prospective control trial in 80 eligible patients with anterior circulation acute ischemic stroke due to large vessel occlusions who received standard-dose (0.9mg/kg) (control group) or non-standard-dose (0.6mg/kg) (intervention group) intravenous thrombolysis and then treated with mechanical thrombectomy; Compare effectiveness by reperfusion rate and 90-day-post-onset modified Rankin scale, compare safety of the methods through the incidence of intracranial hemorrhage complications and mortality. Results: There was no difference between the standard-dose group and the non-standard-dose group in good reperfusion rate (TICI 2b-3: 95% vs. 97.5%, p = 1.00) and good recovery rate at day 90 (modified Rankin scale: 72.5% vs. 82.5%, p = 0.284), the difference was statistically significant when the rates of asymptomatic and symptomatic intracranial hemorrhage were higher in the standard-dose group (12.5% and 27.5%) compared with the non-standard-dose group (0% and 22.5%) (p = 0.048); the mortality was statistically significantly higher in the standard-dose group compared to the non-standard-dose group at day 45 post-stroke (15% vs. 0%, p = 0.026) and tended to be significant at day 90 (17.5% vs. 2.5%, p = 0.057). Conclusion: In patients receiving bridging therapy for acute ischemic stroke, there were no diferrences in reperfusion rate and 90-day good outcome between standard and non-standard dose groups, symptomatic intracranial hemorrhage and mortality were relatively low but tended to be higher in the standard-dose group.Downloads
References
Powers, W. J., et al. (2019), "Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association", Stroke. 50(12), pp. e344-e418.
Saver, Jeffrey L., et al. (2015), "Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke", New England Journal of Medicine. 372(24), pp. 2285-2295.
Campbell, Bruce C.V., et al. (2015), "Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection", New England Journal of Medicine. 372(11), pp. 1009-1018.
Berkhemer, O. A., et al. (2015), "A randomized trial of intraarterial treatment for acute ischemic stroke", N Engl J Med. 372(1), pp. 11-20.
Jovin, Tudor G., et al. (2015), "Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke". 372(24), pp. 2296-2306.
Đào Việt Phương (2019), Nghiên cứu điều trị tắc động mạch lớn hệ tuần hoàn trước trong 6 giờ đầu bằng thuốc tiêu sợi huyết tĩnh mạch kết hợp với lấy huyết khối cơ học, Luận án Tiến sĩ, Đại học Y Hà Nội.
Võ Văn Tân, et al. (2018), "Kết quả điều trị tiêu huyết khối tĩnh mạch kết hợp lấy huyết khối bằng dụng cụ trong điều trị nhồi máu não tối cấp", Y học TP. Hồ Chí Minh. 6(Phụ bản Tập 22), pp. 75-80.
